Surrogates, substudies, and real clinical end points in trials of drug-eluting stents.
Kereiakes
Dean J
DJ
Kuntz
Richard E
RE
Mauri
Laura
L
Krucoff
Mitchell W
MW
D000970:Antineoplastic Agents / Q000008:administration & dosage*; D017327:Clinical Trials, Phase IV as Topic; D003327:Coronary Disease / Q000628:therapy*; D023903:Coronary Restenosis / Q000517:prevention & control*; D006801:Humans; D017239:Paclitaxel / Q000008:administration & dosage*; D016032:Randomized Controlled Trials as Topic; D012107:Research Design; D015607:Stents
D000970:Antineoplastic Agents; D017239:Paclitaxel